{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:10:02Z","timestamp":1790727002225,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Unilever R&D Vlaardingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00394-018-1706-1","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T09:01:41Z","timestamp":1525338101000},"page":"1615-1624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-6958","authenticated-orcid":false,"given":"Wendy A. M.","family":"Blom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wieneke P.","family":"Koppenol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hiemstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Stojakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Scharnagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke A.","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"1706_CR1","volume-title":"Deaths by cause, age, sex, by country and by region, 2000\u20132015","author":"Global Health Estimates 2015","year":"2016","unstructured":"Global Health Estimates 2015 (2016) Deaths by cause, age, sex, by country and by region, 2000\u20132015. World health Organization, Geneva"},{"issue":"32","key":"1706_CR2","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Boren J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen MR, Tokgozoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL (2017) Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 38(32):2459\u20132472. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehx144","journal-title":"Eur Heart J"},{"key":"1706_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2016.05.037","volume":"252","author":"MF Piepoli","year":"2016","unstructured":"Authors\/Task Force M, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I, Verschuren WM (2016) 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 252:207\u2013274. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.05.037","journal-title":"Atherosclerosis"},{"issue":"1","key":"1706_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1476-511X-12-159","volume":"12","author":"J Liu","year":"2013","unstructured":"Liu J, Zeng FF, Liu ZM, Zhang CX, Ling WH, Chen YM (2013) Effects of blood triglycerides on cardiovascular and all-cause mortality: a systematic review and meta-analysis of 61 prospective studies. Lipids Health Dis 12(1):159. \n                    https:\/\/doi.org\/10.1186\/1476-511X-12-159","journal-title":"Lipids Health Dis"},{"issue":"4","key":"1706_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","volume":"115","author":"N Sarwar","year":"2007","unstructured":"Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V (2007) Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115(4):450\u2013458. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.637793","journal-title":"Circulation"},{"issue":"9726","key":"1706_CR6","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/S0140-6736(10)60545-4","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di AE, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J (2010) Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375(9726):1634\u20131639. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)60545-4","journal-title":"Lancet"},{"issue":"17","key":"1706_CR7","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","volume":"362","author":"HN Ginsberg","year":"2010","unstructured":"Ginsberg HN, Elam MB, Lovato LC, Crouse JR III, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP (2010) Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 362(17):1563\u20131574. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1001282","journal-title":"N Engl J Med"},{"issue":"4","key":"1706_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jacl.2016.03.008","volume":"10","author":"KC Maki","year":"2016","unstructured":"Maki KC, Guyton JR, Orringer CE, Hamilton-Craig I, Alexander DD, Davidson MH (2016) Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia. J Clin Lipidol 10(4):905\u2013914. \n                    https:\/\/doi.org\/10.1016\/j.jacl.2016.03.008","journal-title":"J Clin Lipidol"},{"key":"1706_CR9","doi-asserted-by":"publisher","first-page":"CD009753","DOI":"10.1002\/14651858.CD009753.pub2","volume":"11","author":"T Jakob","year":"2016","unstructured":"Jakob T, Nordmann AJ, Schandelmaier S, Ferreira-Gonzalez I, Briel M (2016) Fibrates for primary prevention of cardiovascular disease events. Cochrane Database Syst Rev 11:CD009753. \n                    https:\/\/doi.org\/10.1002\/14651858.CD009753.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1706_CR10","doi-asserted-by":"publisher","unstructured":"Wang D, Liu B, Tao W, Hao Z, Liu M (2015) Fibrates for secondary prevention of cardiovascular disease and stroke. Cochrane Database Syst Rev (10):CD009580. \n                    https:\/\/doi.org\/10.1002\/14651858.CD009580.pub2","DOI":"10.1002\/14651858.CD009580.pub2"},{"issue":"8","key":"1706_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jacc.2013.05.064","volume":"62","author":"H Beltran-Sanchez","year":"2013","unstructured":"Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S (2013) Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999\u20132010. J Am Coll Cardiol 62(8):697\u2013703. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2013.05.064","journal-title":"J Am Coll Cardiol"},{"key":"1706_CR12","unstructured":"F. MCDAKOEGCACL (2015) Prevalence of cholesterol treatment eligibility and medication use among adults\u2014United States, 2005\u20132012. MMWR 64(47):1305\u20131311"},{"issue":"6","key":"1706_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1479164113496828","volume":"10","author":"ND Wong","year":"2013","unstructured":"Wong ND, Patao C, Wong K, Malik S, Franklin SS, Iloeje U (2013) Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: comparison by prevalent cardiovascular disease status. Diab Vasc Dis Res 10(6):505\u2013513. \n                    https:\/\/doi.org\/10.1177\/1479164113496828","journal-title":"Diab Vasc Dis Res"},{"issue":"12","key":"1706_CR14","doi-asserted-by":"publisher","first-page":"e007954","DOI":"10.1136\/bmjopen-2015-007954","volume":"5","author":"S Asghari","year":"2015","unstructured":"Asghari S, Aref-Eshghi E, Godwin M, Duke P, Williamson T, Mahdavian M (2015) Single and mixed dyslipidaemia in Canadian primary care settings: findings from the Canadian primary care sentinel surveillance network database. BMJ Open 5(12):e007954. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-007954","journal-title":"BMJ Open"},{"issue":"1","key":"1706_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","volume":"8","author":"Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel m","year":"2014","unstructured":"Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel m (2014) An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia\u2014full report. J Clin Lipidol 8(1):29\u201360. \n                    https:\/\/doi.org\/10.1016\/j.jacl.2013.12.005","journal-title":"J Clin Lipidol"},{"issue":"39","key":"1706_CR16","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Z, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT, Group ESCSD (2016) 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J 37(39):2999\u20133058. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehw272","journal-title":"Eur Heart J"},{"issue":"4","key":"1706_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1079\/BJN20041234","volume":"92","author":"LM Valsta","year":"2004","unstructured":"Valsta LM, Lemstrom A, Ovaskainen ML, Lampi AM, Toivo J, Korhonen T, Piironen V (2004) Estimation of plant sterol and cholesterol intake in Finland: quality of new values and their effect on intake. Br J Nutr 92(4):671\u2013678","journal-title":"Br J Nutr"},{"issue":"4","key":"1706_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/ajcn\/87.4.993","volume":"87","author":"S Klingberg","year":"2008","unstructured":"Klingberg S, Ellegard L, Johansson I, Hallmans G, Weinehall L, Andersson H, Winkvist A (2008) Inverse relation between dietary intake of naturally occurring plant sterols and serum cholesterol in northern Sweden. Am J Clin Nutr 87(4):993\u20131001","journal-title":"Am J Clin Nutr"},{"key":"1706_CR19","doi-asserted-by":"publisher","unstructured":"Jaceldo-Siegl K, Lutjohann D, Sirirat R, Mashchak A, Fraser GE, Haddad E (2017) Variations in dietary intake and plasma concentrations of plant sterols across plant-based diets among North American adults. Mol Nutr Food Res 61 (8). \n                    https:\/\/doi.org\/10.1002\/mnfr.201600828","DOI":"10.1002\/mnfr.201600828"},{"issue":"1","key":"1706_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00394-011-0297-x","volume":"52","author":"I Demonty","year":"2013","unstructured":"Demonty I, Ras RT, van der Knaap HC, Meijer L, Zock PL, Geleijnse JM, Trautwein EA (2013) The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations: a pooled analysis of 12 randomised controlled trials. Eur J Nutr 52(1):153\u2013160. \n                    https:\/\/doi.org\/10.1007\/s00394-011-0297-x","journal-title":"Eur J Nutr"},{"issue":"2","key":"1706_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1017\/S0007114514000750","volume":"112","author":"RT Ras","year":"2014","unstructured":"Ras RT, Geleijnse JM, Trautwein EA (2014) LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br J Nutr 112(2):214\u2013219. \n                    https:\/\/doi.org\/10.1017\/S0007114514000750","journal-title":"Br J Nutr"},{"issue":"1","key":"1706_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000456723","volume":"70","author":"I Sioen","year":"2017","unstructured":"Sioen I, van Lieshout L, Eilander A, Fleith M, Lohner S, Szommer A, Petisca C, Eussen S, Forsyth S, Calder PC, Campoy C, Mensink RP (2017) Systematic review on N-3 and N-6 polyunsaturated fatty acid intake in European Countries in light of the current recommendations\u2014focus on specific population groups. Ann Nutr Metab 70(1):39\u201350. \n                    https:\/\/doi.org\/10.1159\/000456723","journal-title":"Ann Nutr Metab"},{"issue":"3","key":"1706_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000355437","volume":"63","author":"RK Harika","year":"2013","unstructured":"Harika RK, Eilander A, Alssema M, Osendarp SJ, Zock PL (2013) Intake of fatty acids in general populations worldwide does not meet dietary recommendations to prevent coronary heart disease: a systematic review of data from 40 countries. Ann Nutr Metab 63(3):229\u2013238. \n                    https:\/\/doi.org\/10.1159\/000355437","journal-title":"Ann Nutr Metab"},{"issue":"10","key":"1706_CR24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3945\/jn.114.192229","volume":"144","author":"RT Ras","year":"2014","unstructured":"Ras RT, Demonty I, Zebregs YE, Quadt JF, Olsson J, Trautwein EA (2014) Low doses of eicosapentaenoic acid and docosahexaenoic acid from fish oil dose-dependently decrease serum triglyceride concentrations in the presence of plant sterols in hypercholesterolemic men and women. J Nutr 144(10):1564\u20131570. \n                    https:\/\/doi.org\/10.3945\/jn.114.192229","journal-title":"J Nutr"},{"issue":"6","key":"1706_CR25","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/jn\/138.6.1086","volume":"138","author":"MA Micallef","year":"2008","unstructured":"Micallef MA, Garg ML (2008) The lipid-lowering effects of phytosterols and (n-3) polyunsaturated fatty acids are synergistic and complementary in hyperlipidemic men and women. J Nutr 138(6):1086\u20131090","journal-title":"J Nutr"},{"issue":"6","key":"1706_CR26","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1093\/ajcn\/84.6.1534","volume":"84","author":"I Demonty","year":"2006","unstructured":"Demonty I, Chan YM, Pelled D, Jones PJ (2006) Fish-oil esters of plant sterols improve the lipid profile of dyslipidemic subjects more than do fish-oil or sunflower oil esters of plant sterols. Am J Clin Nutr 84(6):1534\u20131542","journal-title":"Am J Clin Nutr"},{"key":"1706_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1476-511X-6-28","volume":"6","author":"PJ Jones","year":"2007","unstructured":"Jones PJ, Demonty I, Chan YM, Herzog Y, Pelled D (2007) Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects. Lipids Health Dis 6:28. \n                    https:\/\/doi.org\/10.1186\/1476-511X-6-28","journal-title":"Lipids Health Dis"},{"issue":"4","key":"1706_CR28","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/jn\/136.4.1012","volume":"136","author":"SS AbuMweis","year":"2006","unstructured":"AbuMweis SS, Vanstone CA, Ebine N, Kassis A, Ausman LM, Jones PJ, Lichtenstein AH (2006) Intake of a single morning dose of standard and novel plant sterol preparations for 4 weeks does not dramatically affect plasma lipid concentrations in humans. J Nutr 136(4):1012\u20131016","journal-title":"J Nutr"},{"issue":"5\u20136","key":"1706_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10557-010-6249-5","volume":"24","author":"R Bitzur","year":"2010","unstructured":"Bitzur R, Cohen H, Cohen T, Dror TW, Herzog Y, Lifshitz Y, Lubish T, Harats D, Rubinstein A (2010) The metabolic effects of omega-3 plant sterol esters in mixed hyperlipidemic subjects. Cardiovasc Drugs Ther 24(5\u20136):429\u2013437. \n                    https:\/\/doi.org\/10.1007\/s10557-010-6249-5","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"1706_CR30","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1017\/S0007114509297170","volume":"102","author":"S Khandelwal","year":"2009","unstructured":"Khandelwal S, Demonty I, Jeemon P, Lakshmy R, Mukherjee R, Gupta R, Snehi U, Niveditha D, Singh Y, van der Knaap HC, Passi SJ, Prabhakaran D, Reddy KS (2009) Independent and interactive effects of plant sterols and fish oil n-3 long-chain polyunsaturated fatty acids on the plasma lipid profile of mildly hyperlipidaemic Indian adults. Br J Nutr 102(5):722\u2013732. \n                    https:\/\/doi.org\/10.1017\/S0007114509297170","journal-title":"Br J Nutr"},{"issue":"2","key":"1706_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3945\/jn.108.095125","volume":"139","author":"I Demonty","year":"2009","unstructured":"Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA (2009) Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 139(2):271\u2013284. \n                    https:\/\/doi.org\/10.3945\/jn.108.095125","journal-title":"J Nutr"},{"issue":"6","key":"1706_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11883-011-0210-3","volume":"13","author":"MY Wei","year":"2011","unstructured":"Wei MY, Jacobson TA (2011) Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Curr Atheroscler Rep 13(6):474\u2013483. \n                    https:\/\/doi.org\/10.1007\/s11883-011-0210-3","journal-title":"Curr Atheroscler Rep"},{"key":"1706_CR33","volume-title":"Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis","author":"RP Mensink","year":"2016","unstructured":"Mensink RP (2016) Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis. World Health Organization, Geneva"},{"issue":"5","key":"1706_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.5114\/aoms.2017.69326","volume":"13","author":"AFG Cicero","year":"2017","unstructured":"Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M, Fras Z, Katsiki N, Langlois M, Latkovskis G, Panagiotakos DB, Paragh G, Mikhailidis DP, Mitchenko O, Paulweber B, Pella D, Pitsavos C, Reiner Z, Ray KK, Rizzo M, Sahebkar A, Serban MC, Sperling LS, Toth PP, Vinereanu D, Vrablik M, Wong ND, Banach M (2017) Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Arch Med Sci 13(5):965\u20131005. \n                    https:\/\/doi.org\/10.5114\/aoms.2017.69326","journal-title":"Arch Med Sci"},{"key":"1706_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12493","author":"S AbuMweis","year":"2017","unstructured":"AbuMweis S, Jew S, Tayyem R, Agraib L (2017) Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials. J Hum Nutr Diet. \n                    https:\/\/doi.org\/10.1111\/jhn.12493","journal-title":"J Hum Nutr Diet"},{"issue":"3","key":"1706_CR36","doi-asserted-by":"publisher","first-page":"707","DOI":"10.5740\/jaoacint.SGERideout","volume":"98","author":"TC Rideout","year":"2015","unstructured":"Rideout TC, Marinangeli CP, Harding SV (2015) Triglyceride-lowering response to plant sterol and stanol consumption. J AOAC Int 98(3):707\u2013715. \n                    https:\/\/doi.org\/10.5740\/jaoacint.SGERideout","journal-title":"J AOAC Int"},{"issue":"1","key":"1706_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12944-016-0286-4","volume":"15","author":"J Backes","year":"2016","unstructured":"Backes J, Anzalone D, Hilleman D, Catini J (2016) The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids Health Dis 15(1):118. \n                    https:\/\/doi.org\/10.1186\/s12944-016-0286-4","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1706_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12944-017-0541-3","volume":"16","author":"J Oscarsson","year":"2017","unstructured":"Oscarsson J, Hurt-Camejo E (2017) Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review. Lipids Health Dis 16(1):149. \n                    https:\/\/doi.org\/10.1186\/s12944-017-0541-3","journal-title":"Lipids Health Dis"},{"issue":"4","key":"1706_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/01.mol.0000236363.63840.16","volume":"17","author":"WS Harris","year":"2006","unstructured":"Harris WS, Bulchandani D (2006) Why do omega-3 fatty acids lower serum triglycerides? Curr Opin Lipidol 17(4):387\u2013393. \n                    https:\/\/doi.org\/10.1097\/01.mol.0000236363.63840.16","journal-title":"Curr Opin Lipidol"},{"issue":"9","key":"1706_CR40","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/mnfr.201500152","volume":"59","author":"DM Jacobs","year":"2015","unstructured":"Jacobs DM, Mihaleva VV, van Schalkwijk DB, de Graaf AA, Vervoort J, van Dorsten FA, Ras RT, Demonty I, Trautwein EA, van Duynhoven J (2015) The effect of plant sterols and different low doses of omega-3 fatty acids from fish oil on lipoprotein subclasses. Mol Nutr Food Res 59(9):1745\u20131757. \n                    https:\/\/doi.org\/10.1002\/mnfr.201500152","journal-title":"Mol Nutr Food Res"},{"issue":"10","key":"1706_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11883-016-0614-1","volume":"18","author":"MR Taskinen","year":"2016","unstructured":"Taskinen MR, Boren J (2016) Why is apolipoprotein CIII emerging as a novel therapeutic target to reduce the burden of cardiovascular disease? Curr Atheroscler Rep 18(10):59. \n                    https:\/\/doi.org\/10.1007\/s11883-016-0614-1","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"1706_CR42","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1017\/S1368980011002254","volume":"15","author":"J Zheng","year":"2012","unstructured":"Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D (2012) Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr 15(4):725\u2013737. \n                    https:\/\/doi.org\/10.1017\/S1368980011002254","journal-title":"Public Health Nutr"},{"key":"1706_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.5205","author":"T Aung","year":"2018","unstructured":"Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, Chew EY, Bosch J, Collins R, Lewington S, Armitage J, Clarke R (2018) Omega-3 treatment trialists. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 individuals. JAMA Cardiol. \n                    https:\/\/doi.org\/10.1001\/jamacardio.2017.5205","journal-title":"JAMA Cardiol"},{"issue":"4","key":"1706_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1056\/NEJMoa1203859","volume":"367","author":"J Bosch","year":"2012","unstructured":"Bosch J, Gerstein HC, Dagenais GR, Diaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Ryden LE, Yusuf S (2012) n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 367(4):309\u2013318. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1203859","journal-title":"N Engl J Med"},{"issue":"10","key":"1706_CR45","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/2012.jama.11374","volume":"308","author":"EC Rizos","year":"2012","unstructured":"Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 308(10):1024\u20131033. \n                    https:\/\/doi.org\/10.1001\/2012.jama.11374","journal-title":"JAMA"},{"issue":"15","key":"1706_CR46","doi-asserted-by":"publisher","first-page":"e867\u2013e884","DOI":"10.1161\/CIR.0000000000000482","volume":"135","author":"DS Siscovick","year":"2017","unstructured":"Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris-Etherton PM, Jacobson TA, Engler MB, Alger HM, Appel LJ, Mozaffarian D, American Heart Association Nutrition Committee of the Council on L, Cardiometabolic H, Council on E, Prevention, Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Clinical C (2017) Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation 135 (15):e867\u2013e884. \n                    https:\/\/doi.org\/10.1161\/CIR.0000000000000482","journal-title":"Circulation"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-018-1706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-018-1706-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-018-1706-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T20:09:19Z","timestamp":1566936559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-018-1706-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1007\/s00394-018-1706-1","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors, W.A.M.B., W.P.K., H.H. and E.A.T. were all employed by Unilever, the sponsor of this study, when the study was performed. T.S. and H.S. declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by an independent ethics committee (Ethikkommission Ethikausschuss 1 am Campus Charit\u00e9\u2014Mitte, Germany) and was conducted in accordance with applicable laws and regulations including, but not limited to, the International Conference on Harmonization (ICH), Guideline for Good Clinical Practice (GCP) and the ethical principles that have their origins in the Declaration of Helsinki. The study was registered at clinicaltrials.gov (NCT 02728583). All participants gave their written informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standards"}}]}}